GEHC News

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2025. GE HealthCare President and CEO Peter Arduini said, “In our third year as a public company, we’ve made great strides executing our strategy focused on precision care, growth acceleration, and business optimization. We delivered a strong quarter and year with growth in Pharmaceutical Diagnostics, Imaging, and Advanced Visualization Solutions. This

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) and Mayo Clinic today announced the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious new collaboration that aims to transform personalized radiation therapy and cancer care. Building on decades of collaboration and the original Strategic Radiology Research Collaboration signed in 2023, GEMINI-RT plans to drive innovation in prediction, planning, automation, workflow and monitoring for radiation onc

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) management will present at the following upcoming investor conference. Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT GE HealthCare’s CFO, Jay Saccaro, will discuss a variety of topics related to business strategy and growth opportunities. He will also comment on questions that have recently come up related to a competitor receiving FDA approval of an X-Ray contras

(NASDAQ:GEHC) CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease to meet the growing demand for MRI in personalized treatment planning. To complement its MR-guided AI-assisted scanning expertise with analysis and reporting in neurological disease assessment, GE HealthCare expects to integrate the icometrix icobrain p

(NASDAQ:GEHC) ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare and CDL Nuclear Technologies Group enter agreement to distribute Flyrcado to CDL customer sites around the U.S.

(NASDAQ:GEHC) CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of the Vivid™ Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet, completely redesigned to support clinicians with extraordinary imaging in 2D, 4D and color flow, streamlined workflow, and enhanced diagnostic confidence. The ultrasound system recently received CE Mark and U.S. FDA 510(k) clearance. Cardiovascular diseases (CVDs) remain the leading cause of death in the worl

CHICAGO--(BUSINESS WIRE)--Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare (Nasdaq: GEHC) introduced its latest suite of cardiology innovations designed to enhance clinical decision-making, improve workflow efficiency, and support earlier diagnosis and treatment of cardiovascular disease (CVD)—the world’s leading cause of death, responsible for an estimated 20.5 million deaths globally.i “Cardiovascular disease continues to place an immense and growing

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. 2025 Wells Fargo Healthcare Conference – Thursday, September 4, 2025 at 8:45 am ET/7:45 am CT Morgan Stanley 23rd Annual Global Healthcare Conference – Tuesday, September 9, 2025 at 9:15 am ET/8:15 am CT Webcasts of these events can be accessed at the GE HealthCare website: https://investor.gehealthcare.com/news-events/events on th

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) proudly announces the combination of GE HealthCare’s proprietary features and algorithms with MIM Encore, marking a significant milestone in its mission to deliver precision care through advanced digital solutions. This implementation brings powerful new features to healthcare organizations boasting GE HealthCare systems alongside MIM software with MIM Encore, a cutting-edge, single platform design based on user input to help enhance diagno

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) proudly announces the combination of GE HealthCare’s proprietary features and algorithms with MIM Encore, marking a significant milestone in its mission to deliver precision care through advanced digital solutions. This implementation brings powerful new features to healthcare organizations boasting GE HealthCare systems alongside MIM software with MIM Encore, a cutting-edge, single platform design based on user input to help enhance diagno

GE HealthCare beats Q1 estimates and sees strong order growth, but tariff concerns prompt analysts to cut price targets despite a positive outlook.

GE HealthCare beat Q1 expectations with strong EPS, revenue, and order growth, while revising 2025 guidance due to tariffs and cash flow impacts.

GE HealthCare Q4 earnings beat estimates with strong U.S. demand. 2025 outlook includes 2%-3% revenue growth and EPS guidance of $4.61-$4.75.